𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferons Modify in Vitro Proliferation of Human Bladder Transitional Cell Carcinoma in the Presence of Doxorubicin and Mitomycin C

✍ Scribed by Okamoto, E.; Kinne, R.K.H.; Sokeland, J.

Book ID
122990401
Publisher
Lippincott Williams and Wilkins
Year
1996
Tongue
English
Weight
435 KB
Volume
156
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Mitomycin c in the treatment of metastat
Mitomycin c in the treatment of metastatic transitional cell carcinoma of urinary bladder
✍ K. Early; E. G. Elias; A. Mittelman; D. Albert; G. P. Murphy πŸ“‚ Article πŸ“… 1973 πŸ› John Wiley and Sons 🌐 English βš– 515 KB

Mitomycin C was administered t o 21 patients with metastatic transitional cell carcinoma of the urinary bladder. O f these, 19 patients were evaluable. Objective response occurred in f o u r patients, or 21 %. Hemopoietic depression was common and was dose related. Nephrotoxicity related t o the dr

Efficacy of intravesical mitomycin C in
Efficacy of intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the urinary bladder
✍ Abraham Pavlotsky; Abraham Eidelman; Frida Barak; Haim Alon; Dr. Yoav Horn πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 301 KB πŸ‘ 1 views

We treated 47 patients with recurrent transitional cell carcinoma of the bladder with intravesical chemotherapy. Twenty milligrams of mitomycin C per treatment was introduced 7 days after transurethral resection (TUR) or diagnostic cystoscopy, and was repeated at 2-week intervals for five times foll